NCT07495189

Brief Summary

The main purpose of the study is to explore the mechanisms by which mood and sleep disorders interact. The exploratory aim of this study is to discover the relationship between ECG/MCG and EEG/MEG characteristics and mood and sleep disorders and to discover the correlation between cardio-brain monitoring and to explore the mechanisms by which mood and sleep disorders influence each other.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for all trials

Timeline
18mo left

Started Oct 2024

Typical duration for all trials

Geographic Reach
1 country

2 active sites

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress51%
Oct 2024Oct 2027

Study Start

First participant enrolled

October 1, 2024

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

July 28, 2025

Completed
8 months until next milestone

First Posted

Study publicly available on registry

March 27, 2026

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2027

Expected
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2027

Last Updated

March 27, 2026

Status Verified

February 1, 2026

Enrollment Period

2.9 years

First QC Date

July 28, 2025

Last Update Submit

March 22, 2026

Conditions

Keywords

sleep disorderHeart-brain axismagnetoencephalographymagnetocardiography

Outcome Measures

Primary Outcomes (7)

  • High-Frequency Power of Heart Rate Variability

    High-frequency power component of heart rate variability (HF-HRV) derived from electrocardiographic spectral analysis, reflecting parasympathetic (vagal) activity. HF-HRV is reported in milliseconds squared (ms²).

    Baseline (5 minutes); during each 3-minute musical stimulus; post-stimulus baseline (5 minutes)

  • Low-Frequency Power of Heart Rate Variability

    Low-frequency power component of heart rate variability derived from electrocardiographic spectral analysis during baseline and musical stimulation periods, reflecting combined sympathetic and parasympathetic modulation, reported in milliseconds squared (ms²).

    5-minute baseline; during each 3-minute musical stimulus; 5-minute post-stimulus baseline

  • Magnetocardiographic Frequency-Domain Parameters

    Magnetocardiographic Frequency-Domain Parameters - measured in Tesla squared per Hertz (T²/Hz) to analyze spectral properties of cardiac magnetic signals, including power spectral density and energy distribution across frequency bands.

    A 5-minute baseline measurement; 5 different musical stimuli, each lasting 3 minutes; a 5-minute baseline measurement

  • Electroencephalographic Event-Related Potential Components

    Electroencephalographic Event-Related Potential Components - measured in microvolts (µV) to quantify electrical brain response amplitudes and latencies in milliseconds during cognitive and emotional processing tasks.

    A 5-minute baseline measurement; responses during five different musical stimuli, each lasting 3 minutes; a second 5-minute baseline measurement

  • Electroencephalographic Oscillatory Power

    Electroencephalographic Oscillatory Power - measured in decibels (dB) to assess rhythmic neural activity power within specific frequency bands including alpha, beta, theta, gamma, and delta oscillations.

    A 5-minute baseline measurement; responses during five different musical stimuli, each lasting 3 minutes; a second 5-minute baseline measurement

  • Magnetoencephalographic Event-Related Field Components

    Magnetoencephalographic Event-Related Field Components - measured in Tesla (T) to evaluate magnetic brain response amplitudes and latencies in milliseconds during cognitive and emotional processing tasks.

    A 5-minute baseline measurement; responses during five different musical stimuli, each lasting 3 minutes; a second 5-minute baseline measurement

  • Magnetoencephalographic Oscillatory Power

    Magnetoencephalographic Oscillatory Power - measured in decibels (dB) to quantify magnetic field oscillations power within specific frequency bands including alpha, beta, theta, gamma, and delta rhythms.

    A 5-minute baseline measurement; responses during five different musical stimuli, each lasting 3 minutes; a second 5-minute baseline measurement

Secondary Outcomes (10)

  • Demographic Characteristics

    Before the experiment begins

  • Pittsburgh Sleep Quality Index (PSQI)

    Before the experiment begins

  • Hamilton Anxiety Rating Scale (HAMA)

    Before the experiment begins

  • Hamilton Depression Rating Scale (HAMD)

    Before the experiment begins

  • Montreal Cognitive Assessment (MoCA)

    Before the experiment begins

  • +5 more secondary outcomes

Study Arms (4)

Mood disorder with insomnia group

* Meet the above diagnostic criteria for insomnia * Age 18-80 years old * PSQI\>5, ISI\>7, HAMA\>7 and/or HAMD≥7 ④No communication barriers ⑤Signed informed consent form

Other: electrocardiographic/magnetic and electroencephalographic/magnetic monitoring dataDiagnostic Test: ambulatory electrocardiogramOther: General clinical informationOther: scale assessment

Primary insomnia group

①meet the above diagnostic criteria for insomnia * don't meet the above diagnostic criteria for mood disorders * age 18~80 years old * PSQI\>5, ISI\>7, HAMA≤7, and HAMD\<7 ⑤no communication barriers ⑥sign the informed consent form

Other: electrocardiographic/magnetic and electroencephalographic/magnetic monitoring dataDiagnostic Test: ambulatory electrocardiogramOther: General clinical informationOther: scale assessment

Normal healthy group

physical, mental, psychological and social relations are in perfect condition

Other: electrocardiographic/magnetic and electroencephalographic/magnetic monitoring dataDiagnostic Test: ambulatory electrocardiogramOther: General clinical informationOther: scale assessment

Mood disorder without insomnia group

* do not meet the above diagnostic criteria for insomnia ② age 18 - 80 years * PSQI ≤ 5, ISI ≤ 7, HAMA \> 7 and/or HAMD ≥ 7 ④ no communication barriers ⑤ signed informed consent form

Other: electrocardiographic/magnetic and electroencephalographic/magnetic monitoring dataDiagnostic Test: ambulatory electrocardiogramOther: General clinical informationOther: scale assessment

Interventions

First, a 5-minute baseline measurement is performed, and then, 5 different musical stimuli are played in turn, each lasting for 3 minutes. After each music is played, a 1-minute break is arranged. After the last musical stimulation, a 5-minute end measurement is performed to record the final physiological indicators.

Mood disorder with insomnia groupMood disorder without insomnia groupNormal healthy groupPrimary insomnia group

Subjects wore a dynamic ECG for 24 hours before the start of the tria

Mood disorder with insomnia groupMood disorder without insomnia groupNormal healthy groupPrimary insomnia group

General situation collection: Detailed baseline data collection for all participants, including basic demographic characteristics such as age, gender, education level, health status, sleep and lifestyle

Mood disorder with insomnia groupMood disorder without insomnia groupNormal healthy groupPrimary insomnia group

Measure Pittsburgh Sleep Quality Index (PSQI), Insomnia Severity Index (ISI), Montreal Cognitive Assessment Scale (MoCA), Simple Intelligent Mental State Check Scale (MMSE), Hamilton Anxiety Scale (HAMA), Hamilton Depression Scale (HAMD), Epworth Drowsiness Scale (ESS), SF-36 Quality of Life Tables and other related scale information

Mood disorder with insomnia groupMood disorder without insomnia groupNormal healthy groupPrimary insomnia group

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

* Normal health group: physical, mental, psychological and social relations are in perfect condition * Mood disorders with insomnia group: Meet the above diagnostic criteria for Normal health group: physical, mental, psychological and social relations are in perfect condition • Mood disorders with insomnia group: Meet the above diagnostic criteria for insomnia Age 18-80 years old PSQI \> 5, ISI \> 7, HAMA \> 7 and/or HAMD ≥ 7 No communication barriers Signed informed consent form • Mood disorders without insomnia group: Do not meet the above diagnostic criteria for insomnia Age 18-80 years old PSQI ≤ 5, ISI ≤ 7, HAMA \> 7 and/or HAMD ≥ 7 No communication barriers Signed informed consent form • Primary insomnia group: Meet the above diagnostic criteria for insomnia Do not meet the above diagnostic criteria for mood disorders Age 18-80 years old PSQI \> 5, ISI \> 7, HAMA ≤ 7, and HAMD \< 7 No communication barriers Sign the informed consent form

1.Normal health group2.Mood disorders with insomnia group3.Mood disorders without insomnia group4.Primary insomnia group

Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.

Sponsors & Collaborators

Study Sites (2)

Beijing University of Aeronautics and Astronautics

Jinan, Shandong, China

Location

Qilu Hospital of Shandong University

Jinan, Shandong, China

Location

MeSH Terms

Conditions

Sleep Initiation and Maintenance DisordersSleep Wake Disorders

Interventions

Electrocardiography, Ambulatory

Condition Hierarchy (Ancestors)

Sleep Disorders, IntrinsicDyssomniasNervous System DiseasesMental DisordersNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

ElectrocardiographyHeart Function TestsDiagnostic Techniques, CardiovascularDiagnostic Techniques and ProceduresDiagnosisElectrodiagnosisMonitoring, AmbulatoryMonitoring, Physiologic

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 28, 2025

First Posted

March 27, 2026

Study Start

October 1, 2024

Primary Completion (Estimated)

August 31, 2027

Study Completion (Estimated)

October 1, 2027

Last Updated

March 27, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will share

2024-10Network sharing

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
Time Frame
2024.10-2027-10

Locations